Pharmacies and doctors on your phone
As so much of our lives moved to digital, the traditional pharmacy experience hasn’t been able to keep up with shifts. Which is problematic when Amazon is lurking. Amazon has been selling multivitamins, supplements and health foods for many years and has satisfied the rise in consumer concern for immune health, for the likes of Vitamin D tablets, by making them easily accessible while people are stuck at home.
Amazon currently sells these products like everything else it sells, but this is evolving; in the US they have launched their own pharmacy. It should only be a matter of time before talks of a UK roll out accelerate. Of course, Amazon has the advantage of being rooted in an advanced digital platform, but it’s also tapping into demand for digitalised services for all things medical.
We conducted our own research this year and found that over seven million adult consumers in the UK have consulted a doctor online for the first time since the pandemic started, almost 14% of the population. In the US this figure is 39 million. Audiences are clearly becoming accustomed to accessing medical support online, again often through a hybrid model.
Wellness-boosting products and tools, vitamins, gym equipment, supplements, fitness trackers, even mental health tools like colouring books, have all seen a rise in demand. There is no reason why people won’t want to continue using these tools even when doctors’ doors are open.
The new face of Pharma
The global race for vaccines has placed pharmaceutical brands like Pfizer and AstraZeneca firmly on the front pages. This newfound recognition with consumers has coincided with a general shift from pharma companies to act more like B2C brands. These global, complicated, long-established pharmaceutical companies are looking to start ups for inspiration, exploring ways to be more customer-focused while remaining trusted partners for healthcare professionals.
Our global pharma clients have been focusing on reimagining their role in consumers’ lives and how they can provide value that goes beyond the drugs they create. Typically, this includes content, tools, and digital services that help people stay healthier.
This approach has another important role: filling dangerous gaps in information. As Caliber’s 2020 Global Healthcare Study recommended, pharma companies need to talk directly to their consumers rather than assuming they know everything, otherwise people fill in gaps using whatever they hear in the news and online.
The path forward
No one really knows how people will behave in a year’s time and if they claim to, walk away quickly! But we do know some things. That health and wellbeing remains a priority for most people. That the move towards hybrid/digital experience models will continue, offering the flexibility that people demand. And that the brands who offer this will likely thrive over those that don’t.